border=0
border=0
Enter any ticker symbol here to see the live quote & chart tools in action
Ticker:   
border=0 border=0 Benefits: /
  • Your filings are automatically published to your site as they are filed.
  • Investors don't have to leave your site to see filings.


  • Product Description
  • Once a report has been filed with the SEC it will be available on the website.



  • SEC Filings Section 16 Filings Only
     
    NOVADEL PHARMA INC filed this DEF 14A on 10/28/1998.
    « Prev Page Outline Printer Friendly Entire FilingNext Page »
    
    
    
    
    
                                       PROPOSAL 3
    
                   PROPOSAL TO EFFECT A MERGER TO CHANGE THE STATE OF
                INCORPORATION OF THE COMPANY TO DELAWARE AND INCREASE THE
                            AUTHORIZED SHARES OF COMMON STOCK
    
    
    Principal Reasons for the Reincorporation Proposal
    
             The Board of Directors believes that the best interests of the Company
    and its shareholders will be served by changing the Company's state of
    incorporation from New Jersey to Delaware. At the time of the Company's
    incorporation in New Jersey in 1982, the New Jersey Business Corporation Act
    (the "New Jersey Law") was deemed to be adequate for the conduct of the
    Company's business, in part because of the limited business and basic
    organizational features of the Company at that time. Over the years, the
    expansion of the Company's business has increased its need for a more
    sophisticated corporate structure and a more flexible and current regulatory
    foundation.
    
             For many years, Delaware has followed a policy of encouraging
    incorporation in that state and, in furtherance of that policy, has adopted
    comprehensive, modern and adaptable corporation laws which are periodically
    updated and revised to meet changing business needs. Delaware courts have
    developed considerable expertise in dealing with corporate legal issues and a
    substantial body of case law has developed construing Delaware law and
    establishing public policy with respect to Delaware corporations. The relative
    clarity and predictability of Delaware corporate law presented in the numerous
    precedents decided by the Delaware courts should be of great advantage to the
    Company by allowing it to make corporate decisions and take actions with
    increased confidence of what the outcome and consequences of those decisions and
    actions will be under the General Corporation Law of the State of Delaware (the
    "Delaware Law"). Further, the Delaware Secretary of State's office is staffed
    with experienced regulators recognized for their efficient and
    business-sensitive approach to administering the state's business laws and
    regulations. As a result of these and other factors, many major corporations
    have chosen Delaware for their initial domicile or have subsequently
    reincorporated in Delaware in a manner similar to that proposed by the Company.
    
             For the foregoing reasons, the Board of Directors believes that the
    activities of the Company, both present and contemplated, can be better managed
    if the Company were governed by the Delaware Law. It should be noted, however,
    that shareholders in some instances have fewer rights and hence less protection
    under the Delaware Law than under the New Jersey Law. See the discussion under
    the heading "Comparison of Shareholders' Rights under New Jersey Law and
    Delaware Law," below.
    
             On September 29, 1998 the Company's Board of Directors approved,
    subject to shareholder approval, a proposal (the "Reincorporation Proposal") to
    change the Company's state of incorporation from New Jersey to Delaware by means
    of a merger (the "Merger") of the Company with and into Flemington
    Pharmaceutical Corporation ("Flemington Delaware"), a newly formed, wholly-owned
    subsidiary of the Company that has been incorporated under the Delaware Law to
    effect the Reincorporation Proposal. The principal office of Flemington Delaware
    is 43 Emery Avenue, Flemington, New Jersey 08822, telephone (908) 782-3431. If
    the shareholders approve the Reincorporation Proposal, Flemington Delaware will
    be the successor corporation of the Merger. A consequence of this Merger will be
    a change in the law applicable to the Company's corporate affairs, from the New
    Jersey Law to the Delaware Law, which will also result in certain differences in
    shareholders' rights. See "Comparison of Shareholders' Rights under New Jersey
    Law and Delaware Law," below.
    
    
                                           16
    
    




    border=0
    Quote & Chart Package
    Basic Stock Chart
    Basic Stock Quote
    Embedded Quote / Chart
    Embedded Full Quote / Chart
    Interactive Chart
    Intraday Chart
    Pop Up Quote
    Scrolling Ticker

    You are viewing our Quote and Chart Demo using ticker symbol NVDL
    border=0

    T 800.650.1211     F 888.329.6696     E info@stockgroup.com   © 2004 Stockgroup Media Inc.    Disclaimer